VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 634 filers reported holding VANECK VECTORS ETF TR in Q3 2022. The put-call ratio across all filers is 0.65 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $57,000 | +171.4% | 2,356 | +200.1% | 0.01% | +160.0% |
| Q2 2022 | $21,000 | -67.7% | 785 | -53.3% | 0.01% | -58.3% |
| Q1 2022 | $65,000 | +27.5% | 1,682 | +6.3% | 0.01% | +20.0% |
| Q4 2021 | $51,000 | -44.0% | 1,582 | -48.8% | 0.01% | -47.4% |
| Q3 2021 | $91,000 | +18.2% | 3,092 | +36.6% | 0.02% | +18.8% |
| Q2 2021 | $77,000 | -56.2% | 2,263 | -58.2% | 0.02% | -59.0% |
| Q1 2021 | $176,000 | -7.9% | 5,410 | +2.1% | 0.04% | -11.4% |
| Q4 2020 | $191,000 | -50.1% | 5,298 | -78.9% | 0.04% | -54.6% |
| Q3 2020 | $383,000 | +118.9% | 25,101 | +424.2% | 0.10% | +110.9% |
| Q2 2020 | $175,000 | +59.1% | 4,788 | +0.6% | 0.05% | +27.8% |
| Q1 2020 | $110,000 | -73.7% | 4,758 | -79.2% | 0.04% | -72.5% |
| Q4 2018 | $419,000 | 0.0% | 22,850 | 0.0% | 0.13% | 0.0% |
| Q3 2018 | $419,000 | -17.8% | 22,850 | 0.0% | 0.13% | -21.6% |
| Q2 2018 | $510,000 | -82.3% | 22,850 | -81.6% | 0.17% | -82.6% |
| Q4 2017 | $2,889,000 | – | 124,306 | – | 0.96% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |